65. Koldovsky, O., 1989. Search for the role of milk borne biologically active peptides for the suckling. J Nutr,
119 (11), 1543–1551; Buts, J.P., 1998. Bioactive factors in milk, (in French.) Arch Pediatr, 5 (3), 298–306.66. Westrom, B.R. and others, 1987. Levels of immunoreactive insulin, neurotensin, and bombesin in porcine colostreum and milk. / Pediatr Gastroenterol Nutr,
6 (3), 460–465; Ehman, R. and others, 1985. Bombesin, neurotensin and pro-gamma-mel-anotropin in immunoreactants in human milk. Regulatory Peptides, 10 (2–3), 99-105.67. Shutt, D.A. and others, 1985. Comparison of total and free cortisol in bovine serum and milk colostreum. J Dairy Set,
68 (7), 1832–1834.68. Vaarala, O. and others, 1998. Cow milk feeding induces antibodies to insulin in children – a link: between cow milk and insulin-dependent diabetes mellitus? Scandinavian Journal of Immunology
47 (2), 131–135; Slebodzinsky, A.B. and others,1998. Triiodothyronine (T3), insulin and characteristics of 5’-monodiodinase (5’-MD) in mare’s milk from partarition to 21
days post-partum. Reprod Nutr Dev
, 38 (3), 235–244; We-strom, B.R. and others, 1987. Levels of immunoreactive insulin, neurotensin, and bombesin in porcine colostreum and milk. J Pediatr Gastroenterol Nutr, 6 (3), 460–465.69. Ferrando, T. and others, 1990. Beta-endorphin-like and alpha-MSH-like immunoreactivities in human milk. Life Sei
, 47 (7), 633–635.70.Newcomb, P.A. and Egan, K.M., 2006. Dairy food and ovarian cancer risk. The Lancet
, March 2006, 797–799; Stang, A. and others, 2006. Adolescent milk fat and galactose consumption and testicular germ cell cancer. Cancer Epidemiology and Biomarkers Prevention, 15,2189–2195.71. Maruuchi, T. and others, 1998. Effects of gonadotropin-releasing hormone agonist on rat ovarian adenocarcinoma cell lines in vitro and in vivo .Japanese Journal of Cancer Research,
89 (9), 977–983; Kuroda, H. and others, 1998. Human chorionic gonadotrophin (hCG) inhibits cisplatin-induced apoptosis in ovarian cancer cells: possible role of up-regulation of IGF-1 by hCG. Int J Cancer, 76 (4), 571–578; Kurbacher, C.M. and others, 1995. Influence of luteinising hormone on cell growth and С A 125 secretion of primary epithelial ovarian carcinomas in vitro. Tumour Biology, 16 (6), 374–384; Manetta, A. and others, 1995. Inhibition of growth of human ovarian cancer in nude mice by luteinising hormone-releasing hormone antagonist Cetrorelix (SB-75). Fertility and Sterility, 63 (2), 282–287.72. Reiter, E. and others, 1999. Effects of pituitary hormones on the prostate. Prostate
, 38 (2), 159–165; Lamharzi, N. and others, 1998. Luteinising hormone-releasing hormone (LH-RH) antagonist Cetrorelix inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of IGF-2 in tumors. Regulatory Peptides, 77 (113), 185–192; Jungwirth, A. and others, 1997. Luteinising hormone-releasing hormone (LH-RH) antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-2 inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice. Prostate, 32 (3), 164–172; Maeza-wa, H. and others, 1997. Potentiating effect of buserelin ace-t"ate, an LHRH agonist on the proliferation of ventral prostatic epithelial cells in testosterone-treated castrated rats. Int J Urol,4 (4), 411–416; Using, АЖ
and others, 1993. Serological precursors of cancer serum hormones and risk of subsequent prostate cancer. Cancer Epidemiol Biomarkers Prev, 2 (1), 27–32; Garde, S. and others, 1993. Effect of prostatic inhibiting peptide on prostate cancer cell growth in vitro and in vivo. Prostate, 7 (2), 183–194.73. Bosland, M.C., 1996. Hormonal factors in carcinogenesis of the prostate and testis in humans and in animal models. Progress in Clinical and Biological Research
, 394, 309–352.74. Chapman, S. and others, 1992. Changes in adult cigarette consumption per head in 128 countries, 1986–1990. Tobacco Control
, 1,281–284.75. http://www.who.int
76. Chapman, S. and others, 1992. Changes in adult cigarette consumption per head in 128 countries, 1986–1990. Tobacco Control,
, 1.281–284.77. http://www.who.int
78. http://www.13.waisays.com/cancer2.htm
79. Underwood, L.E., D’Ercole, J.A. and Van Wyk, J.J., 1980. So-matomedin-C and the assessment of growth. Ped ClinN Amer,
27, 4, 771–782, and Perdue, J.E 1984. Chemistry, structure and function of insulin-like growth factors and their receptors: a review. Can J Вiochem Cell Bio
, 62, 1237–1245.80. http://vw.com/healthnews/milk.html